Viracta Therapeutics, Inc. - Common Stock (VIRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q2 2025

Type / Class
Equity / Common Stock
Symbol
VIRX
Shares outstanding
19,711,628
Price per share
$0.02
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Viracta Therapeutics, Inc. - Common Stock (VIRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FORWARD VENTURES V LP 4.3% $16,952 847,600 Forward Ventures V, LP 31 Dec 2024

Institutional Holders of Viracta Therapeutics, Inc. - Common Stock (VIRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$3,796 $0.02 0
2025 Q1 171,747 $3,796 -$566,728 $0.02 5
2024 Q4 3,616,059 $582,967 -$433,109 $0.16 31
2024 Q3 5,587,200 $1,291,746 -$1,975,272 $0.23 37
2024 Q2 9,015,600 $4,901,135 -$214,212 $0.54 35
2024 Q1 9,393,424 $9,580,516 -$308,014 $1.02 39
2023 Q4 9,748,088 $5,556,455 -$28,534 $0.57 40
2023 Q3 9,690,886 $10,076,513 -$319,588 $1.04 39
2023 Q2 9,966,868 $14,051,132 -$3,557,037 $1.41 40
2023 Q1 12,218,664 $19,424,749 -$223,575 $1.59 47
2022 Q4 12,370,024 $18,058,661 -$595,250 $1.46 53
2022 Q3 12,353,883 $52,752,000 +$4,215,844 $4.27 52
2022 Q2 11,367,208 $44,104,000 -$5,935,339 $3.88 51
2022 Q1 12,937,982 $61,589,757 -$4,249,351 $4.76 61
2021 Q4 14,157,974 $51,632,505 -$12,428,195 $3.65 62
2021 Q3 15,495,406 $124,371,903 +$15,311,245 $8.02 63
2021 Q2 13,359,302 $151,493,959 +$41,806,201 $11.34 57
2021 Q1 9,928,243 $91,849,085 +$91,828,085 $9.25 43